Skip to content

Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01240395
Enrollment
82
Registered
2010-11-15
Start date
2011-09-30
Completion date
2013-05-31
Last updated
2014-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Chemical Sensitivity

Keywords

Multiple chemical sensitivities, MCS, Mindfulness-based cognitive therapy, MBCT

Brief summary

The objective of this study is to evaluate the effect of mindfulness-based cognitive therapy (MBCT) on physical symptoms attributed to chemical exposures, psychological distress, illness worry, quality of life, and illness perceptions in patients suffering from multiple chemical sensitivity (MCS). Furthermore, a secondary objective is to evaluate whether a possible symptom reduction is mediated by an increased level of mindfulness. The primary hypothesis is that the self-reported severity of MCS symptoms and the degree to which chemical exposures causes symptoms and the impact on daily life will be significantly improved in the MBCT treatment group as compared to the control group.

Interventions

MBCT is partly based on the mindfulness-based stress reduction program (MBSR), developed by Jon Kabat-Zinn and colleagues, and partly on cognitive therapy for depression, the latter influence particularly expressed through the aspect of decentering, meaning not accepting the content of thoughts as facts and not identifying with the thought. The MBCT programme in this study includes 2½ hours of training once a week for 9 weeks. In addition, participants are encouraged to practice at home for up to 45 min per day, 6 days a week during the entire course.

Sponsors

The Danish Research Centre for Chemical Sensitivities
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Fulfil Lacour's criteria for Multiple Chemical Sensitivity * Sign a written informed consent form

Exclusion criteria

* A psychotic or bipolar disorder * An acute psychiatric disorder requiring other treatment * Suicidal ideations * Current alcohol or drug abuse * Previously engaged in a mindfulness programme

Design outcomes

Primary

MeasureTime frameDescription
The Quick Environmental Exposure and Sensitivity Inventory (QEESI)8 weeks, 1 year follow upQEESI is a screening instrument for MCS.

Secondary

MeasureTime frame
The Five Facet Mindfulness Questionnaire (FFMQ)8 weeks, 1 year follow up
The brief illness perception questionnaire (Brief IPQ)8 weeks, 1 year follow up
Symptom Check List 92 (SCL-92)8 weeks, 1 year follow up
The Perceived Stress Scale (PSS-10)8 weeks, 1 year follow up
The World Health Organization Quality of Life (WHOQOL-BREF)8 weeks, 1 year follow-up
Rumination-reflection questionnaire (RRQ)8 weeks, 1 year follow-up
Self compassion scale short form8 weeks, 1 year follow up
The role work functioning index8 weeks, 1 year follow-up

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026